ESC Premium Access

New trends in antithrombotic therapy for atrial fibrillation

Event: ESC CONGRESS 2016
Topic: Atrial fibrillation (AF)
Session type: Rapid Fire Abstracts
Date: 28 August 2016
Time: 11:00 - 12:30

Congress Session

9 presentations in this session

Real world persistence, adherence and switch-over across anticoagulants in atrial fibrillation-a national population-based study.

Speaker: Doctor A. Banerjee (London, GB)
Thumbnail

Patients with atrial fibrillation and history of falls are at high risk for bleeding but have less bleeding with apixaban than warfarin: results from the ARISTOTLE trial

Speaker: Doctor M. Rao (Durham, US)
Thumbnail

Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and active cancer: insights from the ARISTOTLE trial

Speaker: Assistant Professor C. Melloni (Durham, US)
Thumbnail

Linking intrinsic factor X activity, a biologically relevant pharmacodynamic marker, to edoxaban plasma concentration and clinical outcomes in the ENGAGE AF-TIMI 48 trial

Speaker: Doctor O. Yin (Edison, New Jersey, US)
Thumbnail

Direct oral anticoagulants in atrial fibrillation patients undergoing cardioversion. Nationwide multicentre study.

Speaker: Miss S. Itainen-Stromberg (Helsinki, FI)
Thumbnail

When should we start thromboprophylaxis? The stroke risk threshold discrepancy between European and U.S. guidelines for atrial fibrillation

Speaker: Mr P. Nielsen (Aalborg, DK)
Thumbnail

Contemporary results from EHR study of real-world bleeding risk among elderly and overall non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, rivaroxaban and warfarin

Speaker: Doctor R. Horblyuk (New York, US)
Thumbnail

Eligibility criteria for non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in the real world

Speaker: Doctor J. Bicho Augusto (London, GB)
Thumbnail

Changes of oral anticoagulation in elective cardioversion - results from a European cardioversion registry

Speaker: Doctor J. Papp (Pecs, HU)
Thumbnail

9 speakers from this session

Doctor Amitava Banerjee

University College London, London (United Kingdom of Great Britain & Northern Ireland)
5 presentations
0 follower

Doctor Meena Rao

Duke Clinical Research Institute, Durham (United States of America)
0 follower

Assistant Professor Chiara Melloni

Quintiles Transnational Corp., Durham (United States of America)
0 follower

Doctor Ophelia Qiping Yin

Daiichi Sankyo Pharma Development, Edison, New Jersey (United States of America)
0 follower

Miss Saga Itainen-Stromberg

Helsinki University Hospital, Helsinki (Finland)
0 follower

Mr Peter Bronnum Nielsen

Aalborg University Hospital, Aalborg (Denmark)
2 presentations
0 follower

Doctor Ruslan Horblyuk

, New York (United States of America)
0 follower

Doctor Joao Andre Bicho Augusto

Barts Health NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)
2 presentations
0 follower

Doctor Judit Papp

University of Pecs, Pecs (Hungary)
0 follower

This platform is supported by

logo Novo Nordisk